Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ORPH.IR Stock Summary
In the News
ORPH.IR Financial details
Company Rating
Buy
Market Cap
0
Income
-5.27M
Revenue
5.6M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
218
Optionable
No
Shortable
Yes
Earnings
-
P/E
-1090.76
Forward P/E
-
PEG
-81.81
P/S
-
P/B
3.9
P/C
-
P/FCF
-
Quick Ratio
0.76
Current Ratio
1.22
Debt / Equity
0.11
LT Debt / Equity
0.04
-
-
EPS (TTM)
-0.04
EPS next Y
-
EPS next Q
-
EPS this Y
-99.44%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-66.18%
Revenue last 5Y
18.99%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
0.02%
Gross Margin
100%
Oper. Margin
1%
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.14-0.14
52W High
-
52W Low
-
RSI
-
Rel Volume
0.02
Avg Volume
192
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.746004
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
ORPH.IR Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-12-31
Metric | History | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.26 | 0.19 | 0.02 | 0.03 | 0.06 | |
Net income per share | -0.02 | -0.07 | -0.03 | -0.02 | 0 | |
Operating cash flow per share | -0.02 | -0.02 | -0.02 | 0.01 | 0 | |
Free cash flow per share | -0.03 | -0.02 | -0.02 | 0.01 | 0 | |
Cash per share | 0.02 | 0.02 | 0.01 | 0.03 | 0.02 | |
Book value per share | 0.13 | 0.06 | 0.02 | 0.04 | 0.03 | |
Tangible book value per share | 0.07 | 0.05 | 0 | 0.03 | 0.02 | |
Share holders equity per share | 0.13 | 0.06 | 0.02 | 0.04 | 0.03 | |
Interest debt per share | 0 | 0.02 | 0.02 | 0.01 | 0.01 | |
Market cap | 8.44M | 9.14M | 23.11M | 75.79M | 78.68M | |
Enterprise value | 7.42M | 9.56M | 25.21M | 61.38M | 66.13M | |
P/E ratio | -6.18 | -2.12 | -4.13 | -7.02 | -1.06K | |
Price to sales ratio | 0.55 | 0.73 | 7.04 | 3.68 | 2.13 | |
POCF ratio | -7.06 | -9.18 | -8.32 | 18.17 | -50.31 | |
PFCF ratio | -5.09 | -8.56 | -8.25 | 24.61 | -34.16 | |
P/B Ratio | 1.09 | 2.33 | 8.08 | 3.4 | 3.8 | |
PTB ratio | 1.09 | 2.33 | 8.08 | 3.4 | 3.8 | |
EV to sales | 0.48 | 0.76 | 7.68 | 2.98 | 1.79 | |
Enterprise value over EBITDA | -10.43 | -2.61 | -5.36 | -7.03 | 21.55 | |
EV to operating cash flow | -6.21 | -9.6 | -9.08 | 14.72 | -42.28 | |
EV to free cash flow | -4.48 | -8.96 | -9 | 19.94 | -28.72 | |
Earnings yield | -0.16 | -0.47 | -0.24 | -0.14 | 0 | |
Free cash flow yield | -0.2 | -0.12 | -0.12 | 0.04 | -0.03 | |
Debt to equity | 0 | 0.36 | 1.1 | 0.22 | 0.15 | |
Debt to assets | 0 | 0.18 | 0.35 | 0.1 | 0.07 | |
Net debt to EBITDA | 1.44 | -0.11 | -0.45 | 1.65 | -4.09 | |
Current ratio | 2.07 | 2.3 | 0.9 | 1.25 | 1.22 | |
Interest coverage | 0 | -834 | -15.59 | -28.85 | 2.22 | |
Income quality | 0.88 | 0.23 | 0.5 | -0.39 | 21.14 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.28 | 0.28 | 0.54 | 0.53 | 0.48 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.33 | 0.12 | 0.32 | 0.13 | 0.15 | |
Capex to operating cash flow | 0.39 | 0.07 | 0.01 | -0.26 | 0.47 | |
Capex to revenue | -0.03 | -0.01 | -0.01 | -0.05 | -0.02 | |
Capex to depreciation | -0.6 | -0.08 | -0.04 | -0.53 | -0.29 | |
Stock based compensation to revenue | 0 | 0 | 0.03 | 0.01 | 0 | |
Graham number | 0.26 | 0.3 | 0.11 | 0.12 | 0.01 | |
ROIC | -0.18 | -0.81 | -0.71 | -0.33 | -0.01 | |
Return on tangible assets | -0.19 | -0.62 | -0.9 | -0.25 | 0 | |
Graham Net | -0.03 | -0.04 | -0.03 | -0.01 | -0.01 | |
Working capital | 3.28M | 3.75M | -503.2K | 6.01M | 4.64M | |
Tangible asset value | 4.19M | 3.03M | -25.63K | 16.17M | 14.46M | |
Net current asset value | 3.28M | 2.77M | -1.53M | 3.8M | 3.74M | |
Invested capital | 0 | 0.36 | 1.1 | 0.22 | 0.15 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 971.1K | 865.95K | 601.21K | 2.73M | 3.5M | |
Average inventory | 0 | 0 | 0 | 476.5K | 806K | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.18 | -1.1 | -1.95 | -0.48 | 0 | |
Capex per share | -0.01 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-06-30 for Q2
Metric | History | 2020-06-30 | 2020-12-31 | 2021-06-30 | 2021-12-31 | 2022-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | -9.21M | -14.41M | -12.37M | -12.55M | -13.67M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.2 | 0.22 | 0.12 | 0.15 | 0.11 | |
Debt to assets | 0.15 | 0.1 | 0.06 | 0.07 | 0.05 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 2.72 | 1.25 | 1.3 | 1.22 | 1.19 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0.13 | 0 | 0.15 | 0.13 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 11.54M | 6.01M | 5.67M | 4.64M | 4.74M | |
Tangible asset value | 26.71M | 16.17M | 21.77M | 14.46M | 14.6M | |
Net current asset value | 9.27M | 3.8M | 5.13M | 3.74M | 3.95M | |
Invested capital | 0.2 | 0.22 | 0.12 | 0.15 | 0.11 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ORPH.IR Frequently Asked Questions
What is Open Orphan plc stock symbol ?
Open Orphan plc is a GB stock and trading under the symbol ORPH.IR
What is Open Orphan plc stock quote today ?
Open Orphan plc stock price is $- today.
Is Open Orphan plc stock public?
Yes, Open Orphan plc is a publicly traded company.